Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
OncoTargets and Therapy
Volume 14, 2021 - Issue
Case Report
Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report
Yuanyang Zhao1 Department of Respiratory Disease, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212002, People’s Republic of China
https://orcid.org/0000-0001-9541-9434View further author information
https://orcid.org/0000-0001-9541-9434View further author information, Yuxing Chen1 Department of Respiratory Disease, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212002, People’s Republic of Chinahttps://orcid.org/0000-0002-1110-2411View further author information
https://orcid.org/0000-0002-1110-2411View further author information, Huaying Huang1 Department of Respiratory Disease, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212002, People’s Republic of Chinahttps://orcid.org/0000-0002-3628-6480View further author information
https://orcid.org/0000-0002-3628-6480View further author information, , & Hao Ding1 Department of Respiratory Disease, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, 212002, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-5761-9280View further author information
https://orcid.org/0000-0002-5761-9280View further author information